Can nivolumab effectiveness be impacted by patient weight?

Does patient weight change how well nivolumab works?

Patient weight enters calculations for nivolumab dosing, but studies show mixed results on whether it affects clinical outcomes. Some analyses link heavier patients to better responses, while others find no reliable difference.

Why do researchers track patient weight?

Nivolumab started with mg-per-kg dosing, but later trials and approvals switched to flat 240 mg every two weeks or 480 mg every four weeks. Researchers keep studying weight because early dose-finding work showed exposure changes with body mass, and current guidelines still recommend weight-based dosing for some indications.

How does weight-based dosing compare with flat dosing?

Weight-based regimens give 3 mg/kg every two weeks. Flat regimens give constant amounts. Both approaches reach similar average blood levels in most adults. Weight-based dosing produces wider exposure ranges, especially for patients at the extremes of body weight.